Clinical Trial Update: A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis [Phase 2, Phase 3]

View source ↗

Summary

A randomized trial evaluated itraconazole in the acute phase of allergic bronchopulmonary aspergillosis (ABPA) across Phase 2 and Phase 3 stages; the study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Bronchopulmonary Aspergillosis

Drugs mentioned

• Itraconazole (Itraconazole)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Allergic Bronchopulmonary Aspergillosis | Phase 2, Phase 3 | Status: COMPLETED